153 related articles for article (PubMed ID: 7685029)
1. SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking.
Molhuizen HO; Alkemade HA; Zeeuwen PL; de Jongh GJ; Wieringa B; Schalkwijk J
J Biol Chem; 1993 Jun; 268(16):12028-32. PubMed ID: 7685029
[TBL] [Abstract][Full Text] [Related]
2. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.
Alkemade JA; Molhuizen HO; Ponec M; Kempenaar JA; Zeeuwen PL; de Jongh GJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC; Schalkwijk J
J Cell Sci; 1994 Aug; 107 ( Pt 8)():2335-42. PubMed ID: 7983189
[TBL] [Abstract][Full Text] [Related]
3. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties.
Schalkwijk J; de Roo C; de Jongh GJ
Biochim Biophys Acta; 1991 Feb; 1096(2):148-54. PubMed ID: 2001428
[TBL] [Abstract][Full Text] [Related]
4. Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin".
Nara K; Ito S; Ito T; Suzuki Y; Ghoneim MA; Tachibana S; Hirose S
J Biochem; 1994 Mar; 115(3):441-8. PubMed ID: 7914520
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis.
Schalkwijk J; van Vlijmen IM; Alkemade JA; de Jongh GJ
J Invest Dermatol; 1993 Apr; 100(4):390-3. PubMed ID: 8454901
[TBL] [Abstract][Full Text] [Related]
6. Identification and sequence analysis of two new members of the SKALP/elafin and SPAI-2 gene family. Biochemical properties of the transglutaminase substrate motif and suggestions for a new nomenclature.
Zeeuwen PL; Hendriks W; de Jong WW; Schalkwijk J
J Biol Chem; 1997 Aug; 272(33):20471-8. PubMed ID: 9252357
[TBL] [Abstract][Full Text] [Related]
7. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.
Pfundt R; van Ruissen F; van Vlijmen-Willems IM; Alkemade HA; Zeeuwen PL; Jap PH; Dijkman H; Fransen J; Croes H; van Erp PE; Schalkwijk J
J Clin Invest; 1996 Sep; 98(6):1389-99. PubMed ID: 8823304
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of SKALP/Elafin in human epidermal tumors.
Alkemade HA; Molhuizen HO; van Vlijmen-Willems IM; van Haelst UJ; Schalkwijk J
Am J Pathol; 1993 Dec; 143(6):1679-87. PubMed ID: 8256855
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients.
Alkemade H; van de Kerkhof P; Schalkwijk J
J Invest Dermatol; 1992 Jul; 99(1):3-7. PubMed ID: 1607676
[TBL] [Abstract][Full Text] [Related]
10. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions.
Sallenave JM; Silva A
Am J Respir Cell Mol Biol; 1993 Apr; 8(4):439-45. PubMed ID: 8476637
[TBL] [Abstract][Full Text] [Related]
11. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis.
Nonomura K; Yamanishi K; Yasuno H; Nara K; Hirose S
J Invest Dermatol; 1994 Jul; 103(1):88-91. PubMed ID: 8027586
[TBL] [Abstract][Full Text] [Related]
13. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence.
Wiedow O; Schröder JM; Gregory H; Young JA; Christophers E
J Biol Chem; 1990 Sep; 265(25):14791-5. PubMed ID: 2394696
[TBL] [Abstract][Full Text] [Related]
14. Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?
Kuijpers AL; Zeeuwen PL; de Jongh GJ; van de Kerkhof PC; Alkemade HA; Schalkwijk J
Arch Dermatol Res; 1996 Oct; 288(11):641-7. PubMed ID: 8931865
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway.
Pfundt R; Wingens M; Bergers M; Zweers M; Frenken M; Schalkwijk J
Arch Dermatol Res; 2000 Apr; 292(4):180-7. PubMed ID: 10836611
[TBL] [Abstract][Full Text] [Related]
16. Localization of porcine trappin-2 (SKALP/elafin) in trachea and large intestine by in situ hybridization and immunohistochemistry.
Suzuki Y; Furukawa M; Abe J; Kashiwagi M; Hirose S
Histochem Cell Biol; 2000 Jul; 114(1):15-20. PubMed ID: 10959818
[TBL] [Abstract][Full Text] [Related]
17. Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis.
Schalkwijk J; Chang A; Janssen P; De Jongh GJ; Mier PD
Br J Dermatol; 1990 May; 122(5):631-41. PubMed ID: 2354116
[TBL] [Abstract][Full Text] [Related]
18. Elafin, a secretory protein, is cross-linked into the cornified cell envelopes from the inside of psoriatic keratinocytes.
Nakane H; Ishida-Yamamoto A; Takahashi H; Iizuka H
J Invest Dermatol; 2002 Jul; 119(1):50-5. PubMed ID: 12164924
[TBL] [Abstract][Full Text] [Related]
19. The gene of the protease inhibitor SKALP/elafin is a member of the REST gene family.
Lundwall A; Ulvsback M
Biochem Biophys Res Commun; 1996 Apr; 221(2):323-7. PubMed ID: 8619854
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma.
Alkemade HA; van Vlijmen-Willems IM; van Haelst UJ; van de Kerkhof PC; Schalkwijk J
J Pathol; 1994 Oct; 174(2):121-9. PubMed ID: 7965407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
